Molecular mechanisms and clinical studies of iguratimod for the treatment of ankylosing spondylitis
This article reviews the molecular mechanisms of IGU that are related to the pathogenesis of AS and clinical trials of IGU for the treatment of AS, providing a reference for future clinical application of IGU for AS.
Source: Clinical Rheumatology - Category: Rheumatology Source Type: research
More News: Ankylosing Spondylitis | Back Pain | Clinical Trials | Genetics | Men | Pain | Rheumatology | Study